Arabic AR Armenian HY Chinese (Simplified) ZH-CN English EN German DE Greek EL Italian IT Portuguese PT Spanish ES
Traitement de l'hyperplasie bénigne de la prostate pour les hommes canadiens

The UroLift System

The UroLift System is a proven, minimally invasive treatment that fills the gap between prescription medications and more invasive surgical procedures.

Find your BPH symptom score.

Take the one minute test and assess the status of your urinary symptoms.

Consult with our world-class medical experts within days of your call.

How Does it Work?

The UroLift System uses a revolutionary approach to treating BPH that lifts and holds the enlarged prostate tissue so it no longer blocks the urethra

It is the only BPH treatment performed by a urologist that does not require heating, cutting, or removal of the prostate tissue.

The procedure is typically performed using local anesthesia and patients typically return home the same day without a catheter.


An enlarged prostate can narrow or even block the urethra.

First, the UroLift Delivery Device is placed through the obstructed urethra to access the enlarged prostate.

Then, small UroLift implants are permanently placed to lift and hold the enlarged prostate tissue out of the way and increase the opening of the urethra.

Finally, the UroLift Delivery Device is removed, leaving an open urethra designed to provide symptom relief.

Play Video


Treatment with the UroLift System typically takes less than one hour, and does not preclude future UroLift System treatments, TURP, or laser procedures.


After the treatment, patients typically go home the same day without a catheter. There is minimal downtime post-treatment and many patients experience symptom relief in as early as 2 weeks. Patients may experience some urinary discomfort during the recovery period.

Effective BPH symptom relief with minimally invasive and low risk treatments.

Consult with our world-class urologist within days. Contact us now. Why wait?
experienced doctor and urologist in Montreal


The most common side effects of the UroLift System treatment are mild to moderate.

They include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge. Most of these side effects resolve within two to four weeks after the procedure.

There are few long-term risks associated with the UroLift procedure. However, in about 10% of patients, they were required to remove their implants as they were protruding into the bladder, which could cause stone formation if left untreated. Additionally, there is a minor risk of developing a urinary tract infection (UTI) related to cystoscopy procedure, but this is treatable with antibiotics

Read More Read Less


The Implants are intended to be permanent. The implant is made up of standard surgical implantable materials: a nitinol capsular tab, a stainless steel urethral tab, and polyethylene suture that holds the two tabs together. Your doctor can remove the urethral implant, if needed. The suture can be cut and the urethral endpiece can be retrieved with a standard grasper. The capsular tab will remain in place inside the body.
A urologist, a doctor who specializes in the treatment of diseases of the urinary system and sex organs, uses the UroLift System to treat urinary symptoms due to BPH. Comprehensive training is provided to the urologist prior to using the UroLift System.
The UroLift Delivery Device is a single-use, sterile medical device that contains one UroLift Implant. The number of implants used in a procedure is determined by the treating physician and will vary by patient. The Delivery Device is inserted transurethrally through a rigid sheath under cystoscopic visualization in order to reach the targeted area of obstruction.
The UroLift Implants are small permanent implants that hold the obstructing prostatic lobes apart. They are deployed through a needle that comes out of the delivery device. Each implant is made with common implantable materials: nitinol, stainless steel, and suture. The number of implants used in a procedure is determined by the treating physician and will vary by patient.
Your physician will determine which examinations are appropriate for you. The physician will likely ask you to fill out a questionnaire to assess your symptoms, otherwise known as IPSS (International Prostate Symptom Score). This quiz can be found here. Additionally, some of the common examinations include Digital Rectal Exam (DRE), Transrectal Ultrasonography (TRUS), Bladder Ultrasound, and Urinalysis.
Clinical studies have shown the UroLift System treatment does not cause new, sustained instances of erectile or ejaculatory dysfunction. The UroLift System is not intended to treat prior sexual dysfunction.

The UroLift System treatment has been found to be a safe and effective treatment for symptoms related to BPH. Its risk profile is better than reported for most traditional surgical options, and patients report symptom relief better than reported with medications. In the large, pivotal study on the UroLift System, there were no instances of new, sustained erectile dysfunction or ejaculatory dysfunction.


Play Video